Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.89 |
| ▸ | KDM1A | O60341 | 10/20 | 0.62 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.62 |
| ▸ | HTR2A | P28223 | 2/20 | 0.62 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.62 |
| ▸ | PRNP | P04156 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.62 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.62 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.62 |
| ▸ | HTR1A | P08908 | 1/20 | 0.62 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.62 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.62 |
| ▸ | DRD2 | P14416 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.62 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2921645 | 0.88 | PIM1 (0.76) | PIM1KDM1ASIGMAR1HTR2ASLC22A1 | |
| Iodide SCHEMBL31634400 | 0.86 | PIM1 (0.73) | PIM1KDM1ASIGMAR1HTR2ASLC22A1 | |
| Hydrochloric Acid SCHEMBL14697550 | 0.86 | PIM1 (0.73) | PIM1KDM1ASIGMAR1HTR2ASLC22A1 | |
| Iodide SCHEMBL31634399 | 0.86 | PIM1 (0.73) | PIM1KDM1ASIGMAR1HTR2ASLC22A1 | |
| SCHEMBL11346620 | 0.86 | PIM1 (0.68) | PIM1KDM1ASIGMAR1HTR2ASLC22A1 | |
| SCHEMBL21196596 | 0.86 | PIM1 (0.68) | PIM1KDM1ASIGMAR1HTR2ASLC22A1 | |
| Nor2-Chlorpromazine SCHEMBL11202527 | 0.86 | LMNA (0.70) | PIM1KDM1ASIGMAR1HTR2ASLC22A1 | |
| SCHEMBL208025 | 0.86 | PIM1 (0.79) | PIM1KDM1ASIGMAR1HTR2ASLC22A1 | |
| Nor2-Chlorpromazine SCHEMBL14697764 | 0.85 | LMNA (0.70) | PIM1KDM1ASIGMAR1HTR2ASLC22A1 | |
| SCHEMBL10374624 | 0.83 | PIM1 (0.63) | PIM1KDM1ASIGMAR1HTR2ASLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3675814-A1 | COMPOSITION FOR TOPICAL TREATMENT OF NON-MICROORGANISM-CAUSED INFLAMMATORY SKIN AND MUCOUS-MEMBRANE DISEASES | Bläss, Markus (DE) | 2020-07-08 | — | — | EP | claimed |
| WO-2019043064-A1 | COMPOSITION FOR TOPICAL TREATMENT OF NON-MICROORGANISM-CAUSED INFLAMMATORY SKIN AND MUCOUS-MEMBRANE DISEASES | BLAESS MARKUS (DE) | 2019-03-07 | — | — | WO | claimed |
| US-5744429-A | FLOW CONTROL AGENTS | EXXON CHEMICAL PATENTS INC (US) | 1998-04-28 | — | — | US | claimed |
| EP-0375503-B1 | Additives to lubricants resulting from the condensation of an alkylene polyamine onto a copolymer having contiguous carboxylic groups | ELF AQUITAINE (FR) | 1996-02-28 | — | — | EP | claimed |
| US-5055213-A | Addition copolymers containing maleic anhydride monomer modifi ed by a phenothiazine derivative, napthtylamine or diphenylami ne; antideposit agents; dispersants; oxidation resistance | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1991-10-08 | — | — | US | claimed |
| EP-3675814-A1 | COMPOSITION FOR TOPICAL TREATMENT OF NON-MICROORGANISM-CAUSED INFLAMMATORY SKIN AND MUCOUS-MEMBRANE DISEASES | Bläss, Markus (DE) | 2020-07-08 | — | — | EP | disclosed |
| WO-2019043064-A1 | COMPOSITION FOR TOPICAL TREATMENT OF NON-MICROORGANISM-CAUSED INFLAMMATORY SKIN AND MUCOUS-MEMBRANE DISEASES | BLAESS MARKUS (DE) | 2019-03-07 | — | — | WO | disclosed |
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | CELLCEUTIX CORPORATION (US) | 2014-10-16 | — | — | US | disclosed |
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | CELLCEUTIX CORPORATION (US) | 2014-10-16 | — | — | US | disclosed |
| WO-2014093225-A2 | POLYCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | CELLCEUTIX CORPORATION (US) | 2014-06-19 | — | — | WO | disclosed |
| WO-2014086478-A1 | INHIBITORS OF MALT1 PROTEASE | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) | 2014-06-12 | — | — | WO | disclosed |
| WO-2014086478-A1 | INHIBITORS OF MALT1 PROTEASE | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) | 2014-06-12 | — | — | WO | disclosed |
| US-5055213-A | Addition copolymers containing maleic anhydride monomer modifi ed by a phenothiazine derivative, napthtylamine or diphenylami ne; antideposit agents; dispersants; oxidation resistance | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1991-10-08 | — | — | US | disclosed |
| EP-0377358-A2 | Nitrogen-bearing additives having antioxidant properties, and lubricant compositions comprising same | ELF ANTAR FRANCE (FR) | 1990-07-11 | — | — | EP | disclosed |
| EP-0375503-A1 | Additives to lubricants resulting from the condensation of an alkylene polyamine onto a copolymer having contiguous carboxylic groups | ELF AQUITAINE (FR) | 1990-06-27 | — | — | EP | disclosed |
| EP-0200450-B1 | TRICYCLIC DERIVATIVESOF THIADIAZOLE OXIDES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1990-01-03 | — | — | EP | disclosed |
| US-4719174-A | USING ABSORPTIVE COMPOUND WHICH RELEASES ELECTRONS UPON EXPOSURE | FUJI PHOTO FILM CO., LTD. (JP) | 1988-01-12 | — | — | US | disclosed |
| US-4668671-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1987-05-26 | — | — | US | disclosed |
| EP-0200450-A2 | Tricyclic derivativesof thiadiazole oxides | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1986-11-05 | — | — | EP | disclosed |
| US-4607006-A | Silver halide photographic light-sensitive material containing non-spectral sensitizing electron donative silver halide adsorptive compound | FUJI PHOTO FILM CO., LTD. (JP) | 1986-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | ALG1, CD44, MUC1 | PIM1 1725/4885KDM1A 3839/4885SIGMAR1 3419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.